Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$2.8 - $3.72 $184,520 - $245,148
-65,900 Closed
0 $0
Q2 2021

Aug 06, 2021

BUY
$2.61 - $4.17 $91,089 - $145,533
34,900 Added 112.58%
65,900 $245,000
Q1 2021

May 14, 2021

BUY
$2.91 - $4.32 $34,338 - $50,976
11,800 Added 61.46%
31,000 $91,000
Q4 2020

Feb 12, 2021

BUY
$2.15 - $3.5 $41,280 - $67,200
19,200 New
19,200 $58,000

Others Institutions Holding VBIV

About VBI Vaccines Inc


  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $5.17M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.